Annexon Inc (ANNX)
4.66
-0.09
(-1.89%)
USD |
NASDAQ |
May 02, 16:00
4.66
0.00 (0.00%)
After-Hours: 16:13
Annexon Cash from Investing (TTM): 70.70M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 70.70M |
September 30, 2023 | 29.27M |
June 30, 2023 | -4.469M |
March 31, 2023 | 9.709M |
December 31, 2022 | 58.44M |
September 30, 2022 | 135.76M |
June 30, 2022 | 120.38M |
March 31, 2022 | 17.60M |
Date | Value |
---|---|
December 31, 2021 | -88.24M |
September 30, 2021 | -204.80M |
June 30, 2021 | -203.80M |
March 31, 2021 | -120.74M |
December 31, 2020 | -83.16M |
September 30, 2020 | -0.391M |
June 30, 2020 | -0.265M |
March 31, 2020 | -0.267M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-204.80M
Minimum
Sep 2021
135.76M
Maximum
Sep 2022
-16.52M
Average
-0.266M
Median
Cash from Investing (TTM) Benchmarks
Trxade Health Inc | -0.2757M |
P3 Health Partners Inc | -1.827M |
Arrowhead Pharmaceuticals Inc | 49.38M |
Insmed Inc | -223.60M |
Heron Therapeutics Inc | 18.00M |